Benke Małgorzata, Wocial Krzysztof, Lewandowska Weronika, Rutkowski Piotr, Teterycz Paweł, Jarek Piotr, Dedecjus Marek
Department of Endocrinological Oncology and Nuclear Medicine, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland, Roentgen's 5 Str, 02-781 Warszawa, Poland.
Nucl Med Rev Cent East Eur. 2018;21(2):79-84. doi: 10.5603/NMR.a2018.0022. Epub 2018 Jun 29.
Localization and histopathological examination of sentinel lymph node is a standard of melanoma treatment. The first stage of identification of the SLN is the preoperative lymphoscintigraphy. The aim of this study was to assess and compare diagnostic value of planar lymphoscintigraphy and SPECT/CT in sentinel lymph node biopsy procedure performed in patients with cutaneous trunk melanoma.
Between 2015 and 2016, patients with trunk melanoma (N = 255, F/M 95/160), aged from 17 to 88 after an excisional biopsy, with primary tumor ≥ pT1b (AJCC 2009, median Breslow thickness 2.0 ± 3.13) were included in the study. In all the patients PL was followed by SPECT/CT 1-3 hours after injection of 99mTc- colloid particles, and SLNB was performed the next day.
SPECT-CT revealed 78 (18.6%) SLN more than PL, and in 40 patients showed additional lymph drainage regions leading to surgical adjustments. In 18 patients (7.1%) SPECT-CT revealed SLN not visible in the PL (false-negative PL) and in 22 patients (8.6%), foci of uptake interpreted in PL as hot SLNs were found to be non-nodal sites of uptake when assessed on SPECT/CT (false positive PL). SPECT-CT vs. PL mismatch was observed in 31 patients (12.2%) and was the most common in patients with primary lesions located in the anterior inferior medial region (75%).
Results of the presented study indicates the high diagnostic value of SPECT-CT in assessment of SLNs and proved that SPECT-CT increases the sensitivity and accuracy of SLN identification as compared to PL even in very experienced hands.
前哨淋巴结的定位及组织病理学检查是黑色素瘤治疗的标准。前哨淋巴结识别的第一阶段是术前淋巴闪烁显像。本研究的目的是评估和比较平面淋巴闪烁显像与SPECT/CT在躯干皮肤黑色素瘤患者前哨淋巴结活检术中的诊断价值。
2015年至2016年期间,研究纳入了经切除活检后年龄在17至88岁之间、原发性肿瘤≥pT1b(AJCC 2009,中位Breslow厚度2.0±3.13)的躯干黑色素瘤患者(N = 255,女性/男性95/160)。在所有患者中,注射99mTc - 胶体颗粒后1 - 3小时进行平面淋巴闪烁显像,随后进行SPECT/CT检查,次日进行前哨淋巴结活检。
SPECT - CT显示的前哨淋巴结比平面淋巴闪烁显像多78个(18.6%),并且在40例患者中显示出额外的淋巴引流区域,从而导致手术调整。在18例患者(7.1%)中,SPECT - CT显示平面淋巴闪烁显像中未发现的前哨淋巴结(平面淋巴闪烁显像假阴性),在22例患者(8.6%)中,当通过SPECT/CT评估时,平面淋巴闪烁显像中被解释为热前哨淋巴结的摄取灶被发现是非淋巴结摄取部位(平面淋巴闪烁显像假阳性)。在31例患者(12.2%)中观察到SPECT - CT与平面淋巴闪烁显像不匹配,且在位于前下内侧区域的原发性病变患者中最为常见(75%)。
本研究结果表明SPECT - CT在前哨淋巴结评估中具有较高的诊断价值,并证明与平面淋巴闪烁显像相比,即使在经验丰富的医生操作下,SPECT - CT也能提高前哨淋巴结识别的敏感性和准确性。